News blog


  • BY: Andrew Hore |
  • POSTED: 05/03/2019 |

Neuroscience-focused digital data analysis technology developer IXICO is providing data analytics and neuroimaging services for a late phase clinical research programme in Huntingdon’s disease. 

This will generate revenues of £500,000. In the year to September 2018, group revenues were £5.39m. There was £7.86m in the bank at the end of September 2018.

IXICO has been chosen as a partner in the London Medical Imaging and Artificial Intelligence Centre for Value-Based Healthcare. The project is headed up by King’s College and it will develop AI algorithms from NHS medical images and patient data. This will help to speed up diagnosis. 

© 2019 Aim Micro. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

News Blog
All micro news

Quoted Micro 19 August 2019

Continue reading... | 19/08/2019

Omega Diagnostics

Food intolerance and diagnostics company Omega Diagnostics has delayed its interim results announcement, although it figures appear likely to be in line with expectations. 

Continue reading... | 19/08/2019

Transense Technologies

More good news from Transense Technologies and the share price rose by 9.5p to 70.5p. 

Continue reading... | 13/08/2019


Ironveld has entered into confidentiality agreements with potential purchasers of its mining rights for the high-purity iron, vanadium and titanium project in the Bushveld complex in South Africa. 

Continue reading... | 12/08/2019

All micro news

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds